KEGG   DRUG: Maplirpacept
Entry
D12826                      Drug                                   
Name
Maplirpacept (USAN/INN)
Formula
C3436H5316N912O1060S24
Exact mass
77082.3406
Mol weight
77130.05
Sequence
EEELQVIQPD KSVSVAAGES AILHCTVTSL IPVGPIQWFR GAGPARELIY NQKEGHFPRV
TTVSESTKRE NMDFSISISN ITPADAGTYY CVKFRKGSPD TEFKSGAGTE LSVRAKPSES
KYGPPCPPCP APEFLGGPSV FLFPPKPKDT LMISRTPEVT CVVVDVSQED PEVQFNWYVD
GVEVHNAKTK PREEQFNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKGLPS SIEKTISKAK
GQPREPQVYT LPPSQEEMTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS
DGSFFLYSRL TVDKSRWQEG NVFSCSVMHE ALHNHYTQKS LSLSLGK
(Disulfide bridge: 25-91, 161-221, 267-325, 126-126', 129-129', 25'-91', 161'-221', 267'-325')
  Type
Peptide
Efficacy
Antineoplastic
Comment
Treatment of advanced relapsed or refractory lymphoma or myeloma
Target
SIRPA (CD172A) [HSA:140885] [KO:K06551]
  Pathway
hsa04148  Efferocytosis
hsa04380  Osteoclast differentiation
Brite
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Other cell surface molecules
   CD molecules
    SIRPA (CD172A)
     D12826  Maplirpacept (USAN/INN)
Other DBs
CAS: 2631667-06-4
PubChem: 497621239
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system